Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity

Journal of Medicinal Chemistry - United States
doi 10.1021/jm300608w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Design, Synthesis, and Computational Studies of Inhibitors of BCL-Xl

English

Design, Synthesis, and Computational Studies of Inhibitors of BCL-Xl

English

Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic BCL-2 Proteins

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2007English

Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic BCL-2 Proteins

English

Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-Dm1 in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Crystal Structure of ABT-737 Complexed With BCL-xL: Implications for Selectivity of Antagonists of the BCL-2 Family

Cell Death and Differentiation
Cell BiologyMolecular Biology
2007English

Structure-Based Discovery of a New Class of BCL-xL Antagonists

Bioorganic Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular Biology
2007English

Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

BCL-xL in Neuroprotection and Plasticity

Frontiers in Physiology
Physiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy